Page last updated: 2024-09-05

ads j1 and enfuvirtide

ads j1 has been researched along with enfuvirtide in 1 studies

*Enfuvirtide: A synthetic 36-amino acid peptide that corresponds to the heptad repeat sequence of HIV-1 gp41. It blocks HIV cell fusion and viral entry and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS. [MeSH]

Compound Research Comparison

Studies (ads j1)	Trials (ads j1)	Recent Studies (post-2010) (ads j1)	Studies (enfuvirtide)	Trials (enfuvirtide)	Recent Studies (post-2010) (enfuvirtide)
12	0	4	718	89	154

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armand-Ugón, M; Botta, M; Clotet, B; Clotet-Codina, I; Esté, JA; Manetti, F; Tintori, C	1

Other Studies

1 other study(ies) available for ads j1 and enfuvirtide

Article	Year
The anti-HIV activity of ADS-J1 targets the HIV-1 gp120. Virology, 2005, Dec-05, Volume: 343, Issue:1 Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Enfuvirtide; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Molecular Sequence Data; Mutation; Mutation, Missense; Naphthalenesulfonates; Peptide Fragments; Polyelectrolytes; Polymers; Protein Binding; T-Lymphocytes; Triazines; Virus Replication	2005

Article

Year

The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.

Virology, 2005, Dec-05, Volume: 343, Issue:1

Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-HIV Agents; Cell Line; Drug Resistance, Viral; Enfuvirtide; HIV Core Protein p24; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; Humans; Molecular Sequence Data; Mutation; Mutation, Missense; Naphthalenesulfonates; Peptide Fragments; Polyelectrolytes; Polymers; Protein Binding; T-Lymphocytes; Triazines; Virus Replication

2005